Transcriptional links between circadian rhythms and metabolism
Wednesday, February 10, 2016
12:00 pm - 1:00 pm
Mitch Lazar, MD, PhD, University of Pennsylvania
Is GLP-1 a hormone: Whether and when?
Wednesday, February 17, 2016
12:00 pm - 1:00 pm
Dave D'Alessio, MD, Duke
Tumor cell extrinsic processes as targets in tamoxifen-resistant breast cancer
Sponsor(s):
Duke Cancer Institute
Thursday, February 25, 2016
5:00 pm - 6:00 pm
Kimberly Cocce, Duke
Specialized ribosomes: A new frontier in gene regulation, organismal development and evolution
Wednesday, March 09, 2016
12:00 pm - 1:00 pm
Maria Barna, PhD, Stanford University
Genomic analysis of pediatric cancer - basic discovery and clinical applications
Wednesday, March 16, 2016
12:00 pm - 1:00 pm
Alejandro Sweet-Cordero, MD, Stanford University School of Medicine
Duke CRUSH Colorectal Cancer 5K Run/Walk
Sponsor(s):
Duke Cancer Institute
Saturday, March 19, 2016
7:00 am - 10:00 am
Ninth Street, Durham NC
Single Chain VHH for PET Imaging and Targeted Radiotherapy of HER2 Expressing Cancers
Sponsor(s):
Duke Cancer Institute
Thursday, March 24, 2016
5:00 pm - 6:00 pm
Michael Zalutsky, PhD, Duke
Emergent vulnerabilities in breast cancer
Wednesday, March 30, 2016
12:00 pm - 1:00 pm
Benjamin Neel, MD, PhD, NYU School of Medicine
Replicating chromatin: A view from the lagging strand
Wednesday, April 06, 2016
12:00 pm - 1:00 pm
Iestyn Whitehouse, PhD, Sloan Kettering Institute
Role of mutant isocitrate dehydrogenase in biliary cancer
Wednesday, April 13, 2016
12:00 pm - 1:00 pm
Nabeel Bardeesy, PhD, Massachusetts General Hospital Cancer Center
Seminars in Women's Cancer
Sponsor(s):
Duke Cancer Institute
Thursday, April 28, 2016
5:00 pm - 6:00 pm
Susan Murphy, PhD, Duke
Precision medicine for cancer patients using a systems biology approach
Wednesday, May 04, 2016
12:00 pm - 1:00 pm
Charles Perou, PhD, UNC Chapel Hill
Seminars in Women's Cancer
Sponsor(s):
Duke Cancer Institute
Thursday, August 25, 2016
5:00 pm - 6:00 pm
Marni Siegel, UNC School of Medicine
Duke Health Forum 2016: Emerging Healthscape - from Personalized Medicine to Population Health
Sponsor(s):
Policy and Organizational Management Program, Department of Pediatrics, Duke Cancer Institute, Duke University Center for International Studies (DUCIS), and John Hope Franklin Center (JHFC)
Monday, August 29, 2016
12:00 pm - 1:15 pm
CEO of AAP Karen Remley (moderate); Distinguished panelists: Tzou-Yien Lin, Jewel Mullen, Marissa Levine, & Chris Koller
Molecular strategies for enabling the evolution of precision oncology
Wednesday, September 21, 2016
12:00 pm - 1:00 pm
Trever Bivona, MD, PhD, UCSF
Inherited breast and ovarian cancer: 20 years of progress and future directions
Sponsor(s):
Duke Cancer Institute
Thursday, September 22, 2016
5:00 pm - 6:00 pm
Noah Kauff, MD, Duke Cancer Institute
Mechanisms governing metastatic reactivation
Wednesday, October 05, 2016
12:00 pm - 1:00 pm
Filippo Giancotti, MD, PhD, MD Anderson Cancer Center
YAP / TAZ signaling in stem cells and cancer
Wednesday, October 12, 2016
12:00 pm - 1:00 pm
Fernando Camargo, PhD, Boston Children's Hospital
Reading and writing the tubulin code
Wednesday, October 19, 2016
12:00 pm - 1:00 pm
Antonina Roll-Mecak, PhD, NINDS/NIH
Metabolic networks in health and cancer
Wednesday, October 26, 2016
12:00 pm - 1:00 pm
Jason Locasale, PhD, Duke
Seminars in Women's Cancer
Sponsor(s):
Duke Cancer Institute
Thursday, October 27, 2016
5:00 pm - 6:00 pm
Age-related changes to stem cells and the stem cell niche
Wednesday, November 02, 2016
12:00 pm - 1:00 pm
Leanne Jones, PhD, UCLA
Defining functional genomic interactions by comprehensive RNA-chromatin interactome in 3D genome
Wednesday, November 09, 2016
12:00 pm - 1:00 pm
Xiang-Dong Fu, PhD, UCSD
Protein-disaggregase modalities for neurodegenerative disease
Wednesday, November 16, 2016
12:00 pm - 1:00 pm
James Shorter, PhD, University of Pennsylvania
Regulatory Networks in Health and Disease
**CANCELED**
Wednesday, November 30, 2016
12:00 pm - 1:00 pm
Jonathan Weissman, PhD, UCSF
mRNA and tRNA modifications in the regulation of gene expression
Wednesday, December 07, 2016
12:00 pm - 1:00 pm
Tao Pan, PhD, University of Chicago
The Hippo pathway in cell growth, tissue homeostasis, and tumorigenesis
Wednesday, January 18, 2017
12:00 pm - 1:00 pm
Kun-Liang Guan, PhD, UCSD
"Shaping the Future of Cancer"
Sponsor(s):
Department of Community and Family Medicine (Duke CFM), Duke Cancer Institute, and SOM Grand Rounds
Friday, January 20, 2017
1:00 pm - 2:00 pm
Richard Wender, M.D., chief cancer control officer, American Cancer Society, Inc.
Deconstructing p53 pathways in tumor suppression
Wednesday, January 25, 2017
12:00 pm - 1:00 pm
Laura Attardi, PhD, Stanford University
Novel strategies for targeting therapy-resistant tumor cells
Sponsor(s):
Duke Cancer Institute
Thursday, January 26, 2017
5:00 pm - 6:00 pm
Robin Bachelder, PhD, Duke University
Quantitative biology of RASopathies
Wednesday, February 01, 2017
12:00 pm - 1:00 pm
Stanislav Shvartsman, PhD, Princeton University
Targeting the cell cycle for cancer therapy
Wednesday, February 08, 2017
12:00 pm - 1:00 pm
Robert Abraham, PhD, Pfizer
Regulation of hTERT expression by NR4A1 and HOXC5: mechanisms and implications in human cancer and aging
Wednesday, February 15, 2017
12:00 pm - 1:00 pm
Shang Li, PhD, NUS Medical School
Understanding cancer, metastasis and the tumor microenvironment in the age of single-cell genomics
Wednesday, February 22, 2017
12:00 pm - 1:00 pm
Zena Werb, PhD, UCSF
Women's preferences in ovarian cancer treatment decisions
Sponsor(s):
Duke Cancer Institute
Thursday, February 23, 2017
5:00 pm - 6:00 pm
Laura Havrilesky, MD, Duke
Dealing with hunger: how cancer cells adapt to glutamine deprivation
Wednesday, March 01, 2017
12:00 pm - 1:00 pm
Mei Kong, PhD, City of Hope Cancer Center
Mitochondria, lactate, and lipid droplets in neurodegeneration
Wednesday, March 15, 2017
12:00 pm - 1:00 pm
Hugo J Bellen, DVM, PhD, Baylor College of Medicine
Targeting epigenetic vulnerabilities for tumor suppression
Wednesday, March 22, 2017
12:00 pm - 1:00 pm
Jacqueline A. Lees, PhD, MIT
BRAF signaling and tumorigenesis depends upon copper | The role of copper in BRAF-driven thyroid cancer
Sponsor(s):
Duke Cancer Institute
Thursday, March 23, 2017
5:00 pm - 6:00 pm
Chris Counter, PhD and MengMeng Xu, Duke University
More Events
(40 of 181)